お知らせ :東京証券取引所JASDAQスタンダード市場への新規上場に関するお知らせ
株式会社グローバルインフォメーション
市場調査レポート
商品コード
982365

初代培養細胞市場調査レポート:由来別、細胞タイプ別、エンドユーザー別-2025年までの予測-COVID-19の累積的影響

Primary Cells Market Research Report by Origin, by Cell Type, by End-user - Global Forecast to 2025 - Cumulative Impact of COVID-19

出版日: | 発行: 360iResearch LLP | ページ情報: 英文 187 Pages | 納期: 即日から翌営業日

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=107.78円
初代培養細胞市場調査レポート:由来別、細胞タイプ別、エンドユーザー別-2025年までの予測-COVID-19の累積的影響
出版日: 2021年02月04日
発行: 360iResearch LLP
ページ情報: 英文 187 Pages
納期: 即日から翌営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の初代培養細胞の市場規模は、2020年に10億2,578万米ドルとなりました。同市場は、2025年末までに17億3,395万米ドルに達すると予測されています。

COVID-19は、未曾有の世界的な公衆衛生上の緊急事態であり、あらゆる業界に影響を及ぼしてきました。この長期的影響は、予測期間中に業界の成長に影響を与えると予測されています。私たちが進めている調査では、根底にあるCOVID-19の問題と今後の道筋を確実に扱うために、調査範囲を広げています。当レポートは、消費者の行動と需要の変化、購入パターン、サプライチェーンの再ルーティング、現在の市場動向、および政府の重要な介入などを考慮しながら、COVID-19について洞察を提供しています。

当レポートでは、初代培養細胞市場について調査し、市場の概要とともに、由来別、細胞タイプ別、エンドユーザー別、地域別の動向、COVID-19の累積的影響、および市場に参入する企業のプロファイルなどを提供しています。

目次

第1章 序文

  • 調査の目的
  • 市場セグメンテーションと範囲
  • 調査対象年
  • 通貨と価格
  • 言語
  • 制限事項
  • 利害関係者

第2章 調査手法

  • 調査プロセス
    • 定義:調査目的
    • 決定:調査デザイン
    • 準備:調査機器
    • 収集:データソース
    • 分析:データの解釈
    • 策定:データ検証
    • 公開:調査レポート
    • 繰り返し:レポートの更新
  • 調査の実行
    • 開始:調査プロセス
    • 計画:調査計画作成
    • 実行:調査実施
    • 検証:発見と分析
    • 出版物:調査報告
  • 調査成果

第3章 エグゼクティブサマリー

  • イントロダクション
  • 市場の見通し
  • 由来別見通し
  • 細胞タイプ別見通し
  • エンドユーザー別見通し
  • 地域別見通し
  • 競合他社別見通し

第4章 市場概要

  • イントロダクション
  • COVID-19の累積的影響
  • 地理的な成長機会

第5章 市場の洞察

  • 市場力学
    • 促進要因
    • 抑制要因
    • 市場機会
    • 課題
  • ポーターズファイブフォース分析
    • 新規参入業者の脅威
    • 代替品の脅威
    • 顧客の交渉力
    • 供給企業の交渉力
    • 業界の競争

第6章 世界の初代培養細胞市場、由来別

  • イントロダクション
  • 動物
  • ヒト

第7章 世界の初代培養細胞市場、細胞タイプ別

  • イントロダクション
  • 皮膚細胞
  • 胃腸細胞
  • 心臓細胞
  • 造血細胞
  • 肝細胞
    • 凍結保存された肝細胞
    • 新鮮な肝細胞
  • 肺細胞
  • 筋骨格細胞
  • 腎細胞

第8章 世界の初代培養細胞市場、エンドユーザー別

  • イントロダクション
  • ライフサイエンス企業
  • 研究機関

第9章 南北アメリカの初代培養細胞市場

  • イントロダクション
  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋初代培養細胞市場

  • イントロダクション
  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • 韓国
  • タイ

第11章 欧州、中東・アフリカの初代培養細胞市場

  • イントロダクション
  • フランス
  • ドイツ
  • イタリア
  • オランダ
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • FPNVポジショニングマトリックス
    • 象限
    • 事業戦略
    • 製品の満足度
  • 市場ランキング分析
  • 市場シェア分析
  • 競合シナリオ
    • 合併と買収
    • 合意、コラボレーション、およびパートナーシップ
    • 新製品の発売と強化
    • 投資と資金調達
    • 賞、表彰、拡大

第13章 企業のユーザビリティプロファイル

  • AcceGen
  • Allcells
  • American Type Culture Collection
  • Axol Bioscience Ltd.
  • BioIVT
  • Biopredic International
  • BPS Bioscience, Inc.
  • Cell Biologics, Inc.
  • Corning Incorporated
  • Creative Bioarray
  • Epithelix SaRL
  • Ixcells Biotechnologies
  • Lonza Group AG
  • Merck KGaA
  • Neuromics
  • Ppa Research Group, Inc.
  • Promocell GmbH
  • Reachbio LLC
  • Sciencell Research Laboratories, Inc.
  • Sekisui Xenotech, LLC
  • Stem Cell Technologies, Inc.
  • StemExpress, LLC
  • Thermo Fisher Scientific, Inc.
  • Zenbio, Inc.

第14章 付録

  • ディスカッションガイド
図表

List of Figures

  • FIGURE 1. GLOBAL PRIMARY CELLS MARKET: RESEARCH PROCESS
  • FIGURE 2. GLOBAL PRIMARY CELLS MARKET: RESEARCH EXECUTION
  • FIGURE 3. GLOBAL PRIMARY CELLS MARKET SIZE, 2020 VS 2025 (USD MILLION)
  • FIGURE 4. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2020 (USD MILLION)
  • FIGURE 5. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2020 (USD MILLION)
  • FIGURE 6. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2020 (USD MILLION)
  • FIGURE 7. GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 (USD MILLION)
  • FIGURE 8. GLOBAL PRIMARY CELLS MARKET SIZE, 2018-2025 (USD MILLION)
  • FIGURE 9. GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 10. GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 12. GLOBAL PRIMARY CELLS MARKET: MARKET DYNAMICS
  • FIGURE 13. GLOBAL PRIMARY CELLS MARKET: PORTERS FIVE FORCES ANALYSIS
  • FIGURE 14. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2020 VS 2025 (%)
  • FIGURE 15. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2020 VS 2025 (USD MILLION)
  • FIGURE 16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2025
  • FIGURE 17. GLOBAL PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, 2020 VS 2025 (USD MILLION)
  • FIGURE 18. GLOBAL PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, 2020 VS 2025 (USD MILLION)
  • FIGURE 19. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2020 VS 2025 (%)
  • FIGURE 20. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2020 VS 2025 (USD MILLION)
  • FIGURE 21. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2025
  • FIGURE 22. GLOBAL PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, 2020 VS 2025 (USD MILLION)
  • FIGURE 23. GLOBAL PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, 2020 VS 2025 (USD MILLION)
  • FIGURE 24. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEART CELLS, 2020 VS 2025 (USD MILLION)
  • FIGURE 25. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, 2020 VS 2025 (USD MILLION)
  • FIGURE 26. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, 2020 VS 2025 (USD MILLION)
  • FIGURE 27. GLOBAL PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, 2020 VS 2025 (USD MILLION)
  • FIGURE 28. GLOBAL PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, 2020 VS 2025 (USD MILLION)
  • FIGURE 29. GLOBAL PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, 2020 VS 2025 (USD MILLION)
  • FIGURE 30. GLOBAL PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, 2020 VS 2025 (USD MILLION)
  • FIGURE 31. GLOBAL PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, 2020 VS 2025 (USD MILLION)
  • FIGURE 32. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2020 VS 2025 (%)
  • FIGURE 33. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2020 VS 2025 (USD MILLION)
  • FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2025
  • FIGURE 35. GLOBAL PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, 2020 VS 2025 (USD MILLION)
  • FIGURE 36. GLOBAL PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, 2020 VS 2025 (USD MILLION)
  • FIGURE 37. AMERICAS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 38. AMERICAS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 39. COMPETITIVE STRATEGIC WINDOW FOR AMERICAS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 40. ARGENTINA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 41. BRAZIL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 42. CANADA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 43. MEXICO PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 44. UNITED STATES PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 45. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 46. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 47. COMPETITIVE STRATEGIC WINDOW FOR ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 48. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 49. CHINA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 50. INDIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 51. INDONESIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 52. JAPAN PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 53. MALAYSIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 54. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 55. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 56. THAILAND PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 57. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (%)
  • FIGURE 58. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2020 VS 2025 (USD MILLION)
  • FIGURE 59. COMPETITIVE STRATEGIC WINDOW FOR EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2025
  • FIGURE 60. FRANCE PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 61. GERMANY PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 62. ITALY PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 63. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 64. QATAR PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 65. RUSSIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 66. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 67. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 68. SPAIN PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 69. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 70. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD MILLION)
  • FIGURE 71. GLOBAL PRIMARY CELLS MARKET: 360IRESEARCH™ FPNV POSITIONING MATRIX
  • FIGURE 72. GLOBAL PRIMARY CELLS MARKET: 360IRESEARCH™ MARKET SHARE ANALYSIS
  • FIGURE 73. GLOBAL PRIMARY CELLS MARKET: COMPETITOR SWOT ANALYSIS
  • FIGURE 74. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL PRIMARY CELLS MARKET, BY TYPE

List of Tables

  • TABLE 1. CURRENCY CONVERSION RATES
  • TABLE 2. GLOBAL PRIMARY CELLS MARKET SIZE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 3. GLOBAL PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 4. GLOBAL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 5. GLOBAL PRIMARY CELLS MARKET SIZE, BY ANIMAL PRIMARY CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 6. GLOBAL PRIMARY CELLS MARKET SIZE, BY HUMAN PRIMARY CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 7. GLOBAL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 8. GLOBAL PRIMARY CELLS MARKET SIZE, BY DERMATOCYTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 9. GLOBAL PRIMARY CELLS MARKET SIZE, BY GASTROINTESTINAL CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 10. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEART CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 11. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEMATOPOIETIC CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 12. GLOBAL PRIMARY CELLS MARKET SIZE, BY HEPATOCYTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 13. GLOBAL PRIMARY CELLS MARKET SIZE, BY CRYOPRESERVED HEPATOCYTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 14. GLOBAL PRIMARY CELLS MARKET SIZE, BY FRESH HEPATOCYTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 15. GLOBAL PRIMARY CELLS MARKET SIZE, BY LUNG CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 16. GLOBAL PRIMARY CELLS MARKET SIZE, BY MUSCULOSKELETAL CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 17. GLOBAL PRIMARY CELLS MARKET SIZE, BY RENAL CELLS, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 18. GLOBAL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 19. GLOBAL PRIMARY CELLS MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 20. GLOBAL PRIMARY CELLS MARKET SIZE, BY RESEARCH INSTITUTES, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 21. AMERICAS PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 22. AMERICAS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 23. AMERICAS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 24. AMERICAS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 25. ARGENTINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 26. ARGENTINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 27. ARGENTINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 28. BRAZIL PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 29. BRAZIL PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 30. BRAZIL PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 31. CANADA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 32. CANADA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 33. CANADA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 34. MEXICO PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 35. MEXICO PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 36. MEXICO PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 37. UNITED STATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 38. UNITED STATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 39. UNITED STATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 40. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 41. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 42. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 43. ASIA-PACIFIC PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 44. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 45. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 46. AUSTRALIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 47. CHINA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 48. CHINA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 49. CHINA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 50. INDIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 51. INDIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 52. INDIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 53. INDONESIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 54. INDONESIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 55. INDONESIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 56. JAPAN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 57. JAPAN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 58. JAPAN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 59. MALAYSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 60. MALAYSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 61. MALAYSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 62. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 63. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 64. PHILIPPINES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 65. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 66. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 67. SOUTH KOREA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 68. THAILAND PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 69. THAILAND PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 70. THAILAND PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 71. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY GEOGRAPHY, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 72. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 73. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 74. EUROPE, MIDDLE EAST & AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 75. FRANCE PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 76. FRANCE PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 77. FRANCE PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 78. GERMANY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 79. GERMANY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 80. GERMANY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 81. ITALY PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 82. ITALY PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 83. ITALY PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 84. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 85. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 86. NETHERLANDS PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 87. QATAR PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 88. QATAR PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 89. QATAR PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 90. RUSSIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 91. RUSSIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 92. RUSSIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 93. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 94. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 95. SAUDI ARABIA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 96. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 97. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 98. SOUTH AFRICA PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 99. SPAIN PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 100. SPAIN PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 101. SPAIN PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 103. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 104. UNITED ARAB EMIRATES PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 105. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY ORIGIN, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 106. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY CELL TYPE, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 107. UNITED KINGDOM PRIMARY CELLS MARKET SIZE, BY END-USER, 2018-2025 (USD/EUR/GBP/JPY/AUD MILLION)
  • TABLE 108. GLOBAL PRIMARY CELLS MARKET: SCORES
  • TABLE 109. GLOBAL PRIMARY CELLS MARKET: BUSINESS STRATEGY
  • TABLE 110. GLOBAL PRIMARY CELLS MARKET: PRODUCT SATISFACTION
  • TABLE 111. GLOBAL PRIMARY CELLS MARKET: RANKING
  • TABLE 112. GLOBAL PRIMARY CELLS MARKET: MERGER & ACQUISITION
  • TABLE 113. GLOBAL PRIMARY CELLS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 114. GLOBAL PRIMARY CELLS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 115. GLOBAL PRIMARY CELLS MARKET: INVESTMENT & FUNDING
  • TABLE 116. GLOBAL PRIMARY CELLS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 117. GLOBAL PRIMARY CELLS MARKET: LICENSE & PRICING
目次
Product Code: MRR-6263636

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR GBP, JPY, and AUD. This helps organization leaders make better decisions when currency exchange data is readily available.

1. The Global Primary Cells Market is expected to grow from USD 1,025.78 Million in 2020 to USD 1,733.95 Million by the end of 2025.

2. The Global Primary Cells Market is expected to grow from EUR 899.42 Million in 2020 to EUR 1,520.36 Million by the end of 2025.

3. The Global Primary Cells Market is expected to grow from GBP 799.59 Million in 2020 to GBP 1,351.60 Million by the end of 2025.

4. The Global Primary Cells Market is expected to grow from JPY 109,476.92 Million in 2020 to JPY 185,056.78 Million by the end of 2025.

5. The Global Primary Cells Market is expected to grow from AUD 1,489.57 Million in 2020 to AUD 2,517.93 Million by the end of 2025.

Market Segmentation & Coverage:

This research report categorizes the Primary Cells to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Origin, the Primary Cells Market studied across Animal Primary Cells and Human Primary Cells.

Based on Cell Type, the Primary Cells Market studied across Dermatocytes, Gastrointestinal Cells, Heart Cells, Hematopoietic Cells, Hepatocytes, Lung Cells, Musculoskeletal Cells, and Renal Cells. The Hepatocytes further studied across Cryopreserved Hepatocytes and Fresh Hepatocytes.

Based on End-user, the Primary Cells Market studied across Life Science Companies and Research Institutes.

Based on Geography, the Primary Cells Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Company Usability Profiles:

The report deeply explores the recent significant developments by the leading vendors and innovation profiles in the Global Primary Cells Market including AcceGen, Allcells, American Type Culture Collection, Axol Bioscience Ltd., BioIVT, Biopredic International, BPS Bioscience, Inc., Cell Biologics, Inc., Corning Incorporated, Creative Bioarray, Epithelix SaRL, Ixcells Biotechnologies, Lonza Group AG, Merck KGaA, Neuromics, Ppa Research Group, Inc., Promocell GmbH, Reachbio LLC, Sciencell Research Laboratories, Inc., Sekisui Xenotech, LLC, Stem Cell Technologies, Inc., StemExpress, LLC, Thermo Fisher Scientific, Inc., and Zenbio, Inc..

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch™ FPNV Positioning Matrix:

The 360iResearch™ FPNV Positioning Matrix evaluates and categorizes the vendors in the Primary Cells Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

360iResearch™ Competitive Strategic Window:

The 360iResearch™ Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The 360iResearch™ Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and new product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Primary Cells Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Primary Cells Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Primary Cells Market?

4. What is the competitive strategic window for opportunities in the Global Primary Cells Market?

5. What are the technology trends and regulatory frameworks in the Global Primary Cells Market?

6. What are the modes and strategic moves considered suitable for entering the Global Primary Cells Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Stakeholders

2. Research Methodology

  • 2.1. Research Process
    • 2.1.1. Define: Research Objective
    • 2.1.2. Determine: Research Design
    • 2.1.3. Prepare: Research Instrument
    • 2.1.4. Collect: Data Source
    • 2.1.5. Analyze: Data Interpretation
    • 2.1.6. Formulate: Data Verification
    • 2.1.7. Publish: Research Report
    • 2.1.8. Repeat: Report Update
  • 2.2. Research Execution
    • 2.2.1. Initiation: Research Process
    • 2.2.2. Planning: Develop Research Plan
    • 2.2.3. Execution: Conduct Research
    • 2.2.4. Verification: Finding & Analysis
    • 2.2.5. Publication: Research Report
  • 2.3. Research Outcome

3. Executive Summary

  • 3.1. Introduction
  • 3.2. Market Outlook
  • 3.3. Origin Outlook
  • 3.4. Cell Type Outlook
  • 3.5. End-user Outlook
  • 3.6. Geography Outlook
  • 3.7. Competitor Outlook

4. Market Overview

  • 4.1. Introduction
  • 4.2. Cumulative Impact of COVID-19

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing acceptance in drug screening and cell based assays
      • 5.1.1.2. Advantages of primary human cells over other existing methods
      • 5.1.1.3. Growing focus on monoclonal antibodies and personalized medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Common cell culture problems such as contamination
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding biotechnology and biopharmaceutical industries
      • 5.1.3.2. Government as well as private investment in cell-based research
      • 5.1.3.3. Advancements in biomedical research using primary cells
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues in cell biology research field
  • 5.2. Porters Five Forces Analysis
    • 5.2.1. Threat of New Entrants
    • 5.2.2. Threat of Substitutes
    • 5.2.3. Bargaining Power of Customers
    • 5.2.4. Bargaining Power of Suppliers
    • 5.2.5. Industry Rivalry

6. Global Primary Cells Market, By Origin

  • 6.1. Introduction
  • 6.2. Animal Primary Cells
  • 6.3. Human Primary Cells

7. Global Primary Cells Market, By Cell Type

  • 7.1. Introduction
  • 7.2. Dermatocytes
  • 7.3. Gastrointestinal Cells
  • 7.4. Heart Cells
  • 7.5. Hematopoietic Cells
  • 7.6. Hepatocytes
    • 7.6.1. Cryopreserved Hepatocytes
    • 7.6.2. Fresh Hepatocytes
  • 7.7. Lung Cells
  • 7.8. Musculoskeletal Cells
  • 7.9. Renal Cells

8. Global Primary Cells Market, By End-user

  • 8.1. Introduction
  • 8.2. Life Science Companies
  • 8.3. Research Institutes

9. Americas Primary Cells Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Primary Cells Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. South Korea
  • 10.10. Thailand

11. Europe, Middle East & Africa Primary Cells Market

  • 11.1. Introduction
  • 11.2. France
  • 11.3. Germany
  • 11.4. Italy
  • 11.5. Netherlands
  • 11.6. Qatar
  • 11.7. Russia
  • 11.8. Saudi Arabia
  • 11.9. South Africa
  • 11.10. Spain
  • 11.11. United Arab Emirates
  • 11.12. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
    • 12.1.1. Quadrants
    • 12.1.2. Business Strategy
    • 12.1.3. Product Satisfaction
  • 12.2. Market Ranking Analysis
  • 12.3. Market Share Analysis
  • 12.4. Competitor SWOT Analysis
  • 12.5. Competitive Scenario
    • 12.5.1. Merger & Acquisition
    • 12.5.2. Agreement, Collaboration, & Partnership
    • 12.5.3. New Product Launch & Enhancement
    • 12.5.4. Investment & Funding
    • 12.5.5. Award, Recognition, & Expansion

13. Company Usability Profiles

  • 13.1. AcceGen
  • 13.2. Allcells
  • 13.3. American Type Culture Collection
  • 13.4. Axol Bioscience Ltd.
  • 13.5. BioIVT
  • 13.6. Biopredic International
  • 13.7. BPS Bioscience, Inc.
  • 13.8. Cell Biologics, Inc.
  • 13.9. Corning Incorporated
  • 13.10. Creative Bioarray
  • 13.11. Epithelix SaRL
  • 13.12. Ixcells Biotechnologies
  • 13.13. Lonza Group AG
  • 13.14. Merck KGaA
  • 13.15. Neuromics
  • 13.16. Ppa Research Group, Inc.
  • 13.17. Promocell GmbH
  • 13.18. Reachbio LLC
  • 13.19. Sciencell Research Laboratories, Inc.
  • 13.20. Sekisui Xenotech, LLC
  • 13.21. Stem Cell Technologies, Inc.
  • 13.22. StemExpress, LLC
  • 13.23. Thermo Fisher Scientific, Inc.
  • 13.24. Zenbio, Inc.

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing
株式会社グローバルインフォメーション
© Copyright 1996-2021, Global Information, Inc. All rights reserved.